Blood transfusion, while one of the important tools of modern medicine, can bring with it problems such as infection, immune response, increased cost, and resource management. Patient Blood Management (PBM) is an evidence-based and multidisciplinary approach that aims to preserve the patient’s own blood and reduce the need for transfusion. Its main goals are: recognition and treatment of anemia, reduction of blood loss, and optimization of the patient’s physiological tolerance to low hemoglobin levels. Today, PBM has become a patient safety standard integrated into national health policies in many countries.
History and Development
- 1988 – Prof. James Isbister defined the concept of PBM.
- 1990s – Transfusion complications and unnecessary use were debated.
- 1993 – Systematic reviews became widespread with the Cochrane Collaboration.
- 1995 – The OCEBM (Levels of Evidence) approach was adopted.
- 2005 – The three pillars of PBM were clarified (Isbister, 2013).
- 2010 – WHO officially supported PBM and recommended its integration.
- 2012–2013 – Shander & Goodnough defined PBM as the modern standard.
- From 2010 to present – National PBM programs became mandatory in countries like Germany, Austria, Switzerland, etc.
PBM’s Three Core Pillars
1️⃣ Recognition and Treatment of Anemia
- Assessment of preoperative hemoglobin and iron parameters.
- Iron, folate, B12 replacement, and erythropoietin use in appropriate patients.
2️⃣ Reduction of Blood Loss
- Minimally invasive surgical techniques and bleeding control protocols.
- Intraoperative cell saver systems, targeted hemostatic agents (e.g., tranexamic acid).
3️⃣ Optimization of Physiological Reserve
- Supporting adaptation to low hemoglobin levels (improving oxygen transport/delivery balance).
- Transfusion only when clinically necessary (evidence-based approach to thresholds).
Current PBM Applications
- Cardiac surgery: Reduces complications and transfusion needs in high blood loss risk.
- Orthopedics: Improves perioperative blood management in hip/knee replacements.
- Oncology: Provides a holistic approach to chemotherapy-related anemia management.
- Intensive care: Limits unnecessary use of blood products.
- Obstetrics: Helps control potential blood loss during childbirth and C-sections.
PBM is widely accepted worldwide due to its advantages in patient safety, shorter hospital stays, faster recovery, and cost-effectiveness.
Advantages of Patient Blood Management
- Reduces the risks of transfusion-related infections and side effects.
- Shortens hospital stay; accelerates recovery.
- Lowers healthcare costs and improves resource utilization.
- Offers safe options for patients who decline transfusions for religious/personal reasons.
- Improves long-term quality of life and reduces complication rates.
Conclusion
Patient Blood Management (PBM) provides safer, more effective, and more sustainable healthcare by reducing blood transfusions. Especially in major surgeries, well-planned PBM protocols reduce complications and improve outcomes. With the common language of clinical teams, PBM, which combines patient values and current evidence, is a lasting paradigm shift in modern medicine.
Note: This content is for informational purposes only. For diagnosis and treatment, always consult your specialist physician.
References
- Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence Based Medicine: What it is and what it isn’t. BMJ. 1996;312:71-72.
- Guyatt G. Evidence-Based Medicine. JAMA. 1992.
- Isbister JP. The three-pillar matrix of patient blood management. Best Pract Res Clin Anaesthesiol. 2013.
- Shander A, Goodnough LT. Patient Blood Management as Standard of Care. Anesth Analg. 2012.
- Cochrane Collaboration. 1993. cochranelibrary.com
- WHO. Patient Blood Management Policy. 2010. who.int
- Oxford Centre for Evidence-Based Medicine (OCEBM). 1995. cebm.ox.ac.uk
- National Blood Authority, Australia. PBM Guidelines. 2012.
- NEJM. Evidence-Based Clinical Trials. nejm.org
